SCHEDULE 13G: Ramya Rao Discloses 7.26% Passive Stake in Surmodics Inc.
Beneficial Ownership Disclosure
Ramya Rao, a UK-based individual, has disclosed a passive beneficial ownership of 7.26% of Surmodics Inc.'s common stock as of December 31, 2024.
Summary
- Ramya Rao, based in the United Kingdom, has filed a Schedule 13G indicating beneficial ownership of Surmodics Inc. common stock.
- As of December 31, 2024, Ramya Rao beneficially owns 1,039,058 shares of Surmodics Inc. common stock.
- This ownership represents 7.26% of the total outstanding common stock of Surmodics Inc.
- The reporting person has sole voting power and sole dispositive power over all 1,039,058 shares.
- The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Related entities mentioned in the filing include Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd, suggesting an affiliation with the Barclays group.
Sentiment
Score: 6
Explanation: The filing itself is a neutral compliance document. However, the disclosure of a significant passive stake by an institutional investor can be mildly positive as it signals confidence in the company without an intent to disrupt management.
Positives
- A significant stake (7.26%) held by a single entity/individual can signal confidence in the company's long-term prospects.
- The passive nature of the investment (Schedule 13G) suggests it is not intended to influence control, which can be seen as a stable, long-term holding.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Surmodics Inc.'s future performance or outlook.
Industry Context
This filing indicates a significant passive investment by a UK-based entity/individual, potentially associated with Barclays, in Surmodics Inc. Such disclosures are common for institutional investors accumulating stakes above 5% and typically reflect investment decisions rather than operational or strategic shifts within the industry.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by a large investor may provide a degree of confidence or stability regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting date for beneficial ownership) |
| 02/14/2025 | Date of filing/signature of the Schedule 13G statement |
Keywords
Surmodics Inc, beneficial ownership, Schedule 13G, passive investment, equity stake, Ramya Rao, Barclays, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.